A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
Clinical trial NCT03017014 · TERMINATED
Trial details
- NCT number
- NCT03017014
- Sponsor
- AbbVie
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-26
- Primary completion
- 2019-10-14
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.